The Enterprise Value as of September 2024 (TTM) for ANI Pharmaceuticals, Inc. (ANIP) is 1.25B

According to ANI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.25B. This represents a change of 0.27% compared to the average of 1.25B of the last 4 quarters.

ANI Pharmaceuticals, Inc. (ANIP) Historical Enterprise Value (quarterly & annually)

How has ANIP Enterprise Value performed in the past?

The mean historical Enterprise Value of ANI Pharmaceuticals, Inc. over the last ten years is 752.34M. The current 1.25B Enterprise Value has changed 16.58% with respect to the historical average. Over the past ten years (40 quarters), ANIP's Enterprise Value was at its highest in in the March 2024 quarter at 1.38B. The Enterprise Value was at its lowest in in the September 2014 quarter at 282.68M.

ANI Pharmaceuticals, Inc. (ANIP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ANI Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ANI Pharmaceuticals, Inc. (ANIP) Average Enterprise Value

How has ANIP Enterprise Value performed in the past?

The current Enterprise Value of ANI Pharmaceuticals, Inc. (ANIP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ANI Pharmaceuticals, Inc. (ANIP) Enterprise Value vs. Peers

How is ANIP’s Enterprise Value compared to its peers?

ANI Pharmaceuticals, Inc.’s Enterprise Value is greater than Eagle Pharmaceuticals, Inc. (110.42M), less than Phibro Animal Health Corporation (1.31B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (4.72B), less than Alkermes plc (4.38B), less than Dr. Reddy's Laboratories Limited (1.14T), less than Collegium Pharmaceutical, Inc. (1.58B), greater than Pacira BioSciences, Inc. (1.02B), greater than Procaps Group S.A. (476.58M), greater than Silver Spike Investment Corp. (38.50M), less than Neurocrine Biosciences, Inc. (12.54B), less than Amphastar Pharmaceuticals, Inc. (2.77B), less than Ironwood Pharmaceuticals, Inc. (1.26B), greater than InterCure Ltd. (415.21M),

Build a custom stock screener for ANI Pharmaceuticals, Inc. (ANIP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ANI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ANI Pharmaceuticals, Inc. (ANIP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ANI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.